Characterization of mutations contributing to sulfathiazole resistance in Escherichia coli

G Vedantam1, G G Guay, N E Austria

  • 1Department of Biological Sciences, University of Illinois at Chicago, 60607, USA.

Insights

Sulfathiazole resistance in E. coli involves mutations in folP, leading to resistant dihydropteroate synthase (DHPS). Additional mutations, including the bicyclomycin resistance gene (bcr), contribute to higher resistance levels.

Area of Science:

  • Microbiology
  • Genetics
  • Molecular Biology

Background:

  • Sulfathiazole is an antibiotic targeting dihydropteroate synthase (DHPS).
  • Antibiotic resistance mechanisms are crucial for understanding microbial evolution and treatment efficacy.
  • Escherichia coli is a model organism for studying bacterial genetics and resistance.

Purpose of the Study:

  • To identify genetic mutations conferring sulfathiazole resistance in Escherichia coli.
  • To characterize the molecular basis of resistance in laboratory-selected strains.
  • To investigate the contribution of specific genes and mutations to sulfathiazole resistance.

Main Methods:

  • P1 transduction was used to map resistance genes.
  • Nucleotide sequence analysis identified specific mutations.
  • Allelic replacement experiments were performed to assess gene function.
  • Characterization of secondary resistance determinants was conducted.

Main Results:

  • A mutation in the folP gene, identical in two resistant E. coli strains, was identified.
  • This folP mutation resulted in a Pro64Ser substitution in DHPS.
  • The folP mutation alone conferred only low-level sulfathiazole resistance.
  • An amplified secondary resistance determinant, identified as bcr (bicyclomycin resistance), was found.
  • An additional mutation, sux, was identified and affects purine metabolism.

Conclusions:

  • Sulfathiazole resistance in these E. coli strains is multifactorial, involving mutations in folP and other genetic elements.
  • The resistant DHPS (encoded by folP) is necessary but not sufficient for high-level resistance.
  • The bcr gene and the sux mutation contribute significantly to the overall resistance phenotype.
  • Understanding these complex resistance mechanisms is vital for combating antibiotic resistance.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mutations in Microorganisms01:18

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...